{"title":"SGLT-2 抑制剂对 2 型糖尿病患者的全因死亡率有影响吗?","authors":"Laura T. Brusky, Denise Kohl, David Johnson","doi":"10.1097/ebp.0000000000002118","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12164,"journal":{"name":"Evidence-Based Practice","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Do SGLT-2 inhibitors agents have an effect on all-cause mortality in patients with diabetes type 2?\",\"authors\":\"Laura T. Brusky, Denise Kohl, David Johnson\",\"doi\":\"10.1097/ebp.0000000000002118\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12164,\"journal\":{\"name\":\"Evidence-Based Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-Based Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/ebp.0000000000002118\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-Based Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ebp.0000000000002118","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Nursing","Score":null,"Total":0}